Clinical trialNCT01846351CompletedObservational

Intravitreal Anti-VEGF in Exudative AMD With Epiretinal Membranes

SponsorNew England Retina AssociatesEnrollment16Age Related Macular DegenerationEpiretinal Membrane

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Study designed to evaluate the effect of significant ERM on the visual and anatomic outcomes of intravitreal anti-VEGF therapy for eAMD.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Nauman A Chaudhry, MD
New England Retina Associates
Principal Investigator
clinicaltrials.gov ↗
Peter E Liggett, MD
New England Retina Associates
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Jul 2006
Primary completion: 28 Feb 2010
Completion: 28 Feb 2010
Last update posted: 3 May 2013
Registered enrollment: 16
Registry id: NCT01846351

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.